Clinical Trials Directory

Trials / Unknown

UnknownNCT00370721

Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
—
Sponsor
Shahid Beheshti University of Medical Sciences · Academic / Other
Sex
All
Age
—
Healthy volunteers
Not accepted

Summary

To evaluate the effect of intravitreal bevacizumab on the course of diabetic retinopathy in cases with the signs of active progressive PDR

Conditions

Interventions

TypeNameDescription
DRUGbevacizumab

Timeline

Start date
2006-03-01
First posted
2006-09-01
Last updated
2008-06-26

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00370721. Inclusion in this directory is not an endorsement.

Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR) (NCT00370721) · Clinical Trials Directory